|
MORF
|
Morphic Holding, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
MCRB
|
Seres Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
0.01%
|
US
|
NASDAQ
|
|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
0.01%
|
US
|
NASDAQ
|
|
KIDS
|
OrthoPediatrics Corp.
|
0.01%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
INGN
|
Inogen, Inc
|
0.01%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
HSTM
|
HealthStream, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
HSKA
|
Heska Corporation
|
0.01%
|
US
|
NASDAQ
|
|
HRTX
|
Heron Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
HIMS
|
Hims & Hers Health, Inc.
|
0.01%
|
US
|
NYSE
|